The therapeutic dilemma: how to use tadalafil

Int J Androl. 2005 Dec:28 Suppl 2:74-80. doi: 10.1111/j.1365-2605.2005.00590.x.

Abstract

Tadalafil, a type 5 phosphodiesterase inhibitor, is a new and effective therapy for erectile dysfunction. It has unique pharmacokinetic properties in its drug class, which also includes sildenafil and vardenafil. It is also well tolerated with few side-effects, and can be used in difficult patients such as neuropaths or diabetics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Carbolines / adverse effects*
  • Carbolines / classification
  • Carbolines / pharmacokinetics
  • Carbolines / therapeutic use*
  • Diabetes Complications
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / pathology
  • Erectile Dysfunction / complications
  • Erectile Dysfunction / drug therapy*
  • Half-Life
  • Humans
  • Male
  • Nervous System Diseases / complications
  • Penile Erection / drug effects
  • Phosphodiesterase Inhibitors / adverse effects
  • Phosphodiesterase Inhibitors / classification
  • Phosphodiesterase Inhibitors / pharmacokinetics
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Tadalafil
  • Vasodilator Agents / adverse effects
  • Vasodilator Agents / classification
  • Vasodilator Agents / pharmacokinetics
  • Vasodilator Agents / therapeutic use*

Substances

  • Carbolines
  • Phosphodiesterase Inhibitors
  • Vasodilator Agents
  • Tadalafil